{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:16:52Z","timestamp":1789755412098,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.placenta.2010.07.015","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T04:24:29Z","timestamp":1295670269000},"page":"S42-S48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"S1","title":["Screening for Pre-eclampsia\u2013Lessons from Aneuploidy Screening"],"prefix":"10.1016","volume":"32","author":[{"given":"H.S.","family":"Cuckle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2010.07.015_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/sim.4780110211","article-title":"Model-based screening by risk with application to Down\u2019s syndrome","volume":"11","author":"Royston","year":"1992","journal-title":"Stat Med"},{"key":"10.1016\/j.placenta.2010.07.015_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2423(06)43006-7","article-title":"A summary analysis of Down Syndrome markers in the late first trimester","volume":"43","author":"Palomaki","year":"2007","journal-title":"Adv Clin Chem"},{"issue":"4","key":"10.1016\/j.placenta.2010.07.015_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pd.1978","article-title":"First-trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.placenta.2010.07.015_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/uog.6331","article-title":"Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies","volume":"33","author":"Zaragoza","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.placenta.2010.07.015_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/pd.2384","article-title":"Placental protein 13 as a first trimester screening marker for aneuploidy","volume":"29","author":"Koster","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0002-9378(88)90090-7","article-title":"The classification and definition of the hypertensive disorders of pregnancy","volume":"158","author":"Davey","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.placenta.2010.07.015_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/jhh.2009.45","article-title":"Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach","volume":"24","author":"Poon","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.placenta.2010.07.015_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman\u2019s risk of having a pregnancy associated with Down\u2019s syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2010.07.015_bib9","first-page":"386","article-title":"International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age","volume":"36","author":"Carothers","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.placenta.2010.07.015_bib10","series-title":"Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment","first-page":"771","article-title":"Multianalyte maternal serum screening for chromosomal defects","author":"Cuckle","year":"2010"},{"issue":"12","key":"10.1016\/j.placenta.2010.07.015_bib11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.placenta.2010.07.015_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11\u00a0+\u00a00 to 13\u00a0+\u00a06 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/AOG.0b013e318188d6f9","article-title":"First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome","volume":"112","author":"Poon","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.placenta.2010.07.015_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pd.2279","article-title":"Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.placenta.2010.07.015_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pd.990","article-title":"UK National Down\u2019s syndrome screening Programme, Laboratory Advisory Group. Age-standardisation when target setting and auditing performance of Down syndrome screening programmes","volume":"24","author":"Cuckle","year":"2004","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1016\/j.placenta.2010.07.015_bib16","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-0528.2008.01902.x","article-title":"Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study","volume":"115","author":"Gonen","year":"2008","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.placenta.2010.07.015_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","article-title":"Longitudinal determination of serum placental protein 13 during development of Preeclampsia","volume":"24","author":"Huppertz","year":"2008","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1016\/j.placenta.2010.07.015_bib18","doi-asserted-by":"crossref","first-page":"35.e1","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2010.07.015_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pd.1921","article-title":"First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes","volume":"28","author":"Cowans","year":"2008","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.placenta.2010.07.015_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/pd.2287","article-title":"First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk","volume":"29","author":"Khalil","year":"2009","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.placenta.2010.07.015_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A novel screening of early pre-eclampsia in the first trimester combining PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.placenta.2010.07.015_bib22","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.placenta.2010.07.015_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.3876","article-title":"First-trimester maternal serum\u00a0PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia","volume":"29","author":"Spencer","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2010.07.015_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pd.148","article-title":"First trimester maternal serum placental growth factor (PlGF) concentrations in pregnancies with fetal trisomy 21 and trisomy 18","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.placenta.2010.07.015_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2010.07.015_bib26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pd.762","article-title":"ADAM12, a novel first-trimester maternal serum marker for Down syndrome","volume":"23","author":"Laigaard","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pd.1480","article-title":"Maternal serum ADAM12 levels in Down\u2019s and Edwards\u2019 syndrome pregnancies at 9\u201312 weeks gestation","volume":"26","author":"Laigaard","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pd.1540","article-title":"ADAM 12 as a first trimester maternal serum marker in screening for Down\u2019s syndrome","volume":"26","author":"Laigaard","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pd.1994","article-title":"Stamatopoulou A. Maternal serum ADAM12s in the late\u00a0first trimester of pregnancies with Trisomy 21","volume":"28","author":"Cowans","year":"2008","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.placenta.2010.07.015_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pd.1957","article-title":"ADAM12s in maternal serum as a potential marker of pre-eclampsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1016\/j.placenta.2010.07.015_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/pd.2300","article-title":"ADAM12s as a first-trimester screening marker of trisomy","volume":"29","author":"Wortelboer","year":"2009","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.placenta.2010.07.015_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.AOG.0000165829.65319.65","article-title":"Reduction of the disintegrin and metalloprotease ADAM12 in Preeclampsia","volume":"106","author":"Laigaard","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/uog.6212","article-title":"Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia","volume":"32","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.placenta.2010.07.015_bib34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1471-0528.2007.01483.x","article-title":"Accuracy of body mass index in predicting pre-eclampsia: bivariate meta-analysis","volume":"114","author":"Cnossen","year":"2007","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.amjhyper.2006.12.012","article-title":"First-trimester mean arterial pressure and risk of preeclampsia","volume":"20","author":"Miller","year":"2007","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.placenta.2010.07.015_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000235880","article-title":"First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects","volume":"25","author":"Staboulidou","year":"2009","journal-title":"Fetal Diagn Ther"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2010.07.015_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"G\u00f3mez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00016340601155056","article-title":"Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers","volume":"86","author":"Pilalis","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"10.1016\/j.placenta.2010.07.015_bib40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/pd.2383","article-title":"Application of a first-trimester prediction model for pre-eclampsia based on uterine arteries and maternal history in high-risk pregnancies","volume":"29","author":"Herraiz","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/uog.6452","article-title":"Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks","volume":"34","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2010.07.015_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/pd.1665","article-title":"First trimester ADAM12 and as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system","volume":"27","author":"Cowans","year":"2007","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.placenta.2010.07.015_bib43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/humrep\/13.3.744","article-title":"Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down\u2019s syndrome","volume":"13","author":"Renier","year":"1998","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.placenta.2010.07.015_bib44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<372::AID-PD537>3.0.CO;2-O","article-title":"The effect of smoking in pregnancy on maternal serum inhibin A levels","volume":"19","author":"Ferriman","year":"1999","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.placenta.2010.07.015_bib45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.440","article-title":"Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance","volume":"22","author":"Rudnicka","year":"2002","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.placenta.2010.07.015_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7110","article-title":"First and second trimester antenatal screening for Down\u2019s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"7","author":"Wald","year":"2003","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1016\/j.placenta.2010.07.015_bib47","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","article-title":"First and second trimester evaluation of risk (FASTER) Trial research Consortium. Comparison of serum markers in first-trimester Down syndrome screening","volume":"108","author":"Canick","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.placenta.2010.07.015_bib48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.placenta.2010.07.015_bib49","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.placenta.2010.07.015_bib50","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pd.1251","article-title":"Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.placenta.2010.07.015_bib51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pd.2339","article-title":"First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia","volume":"29","author":"D\u2019Anna","year":"2009","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.placenta.2010.07.015_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.1890","article-title":"Low levels of maternal serum PAPP-A in the first triemster and the risk of pre-eclapmsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.07.015_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/uog.7439","article-title":"Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11\u201313 weeks","volume":"34","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400410002845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400410002845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:43:31Z","timestamp":1758908611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400410002845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":53,"alternative-id":["S0143400410002845"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2010.07.015","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Pre-eclampsia\u2013Lessons from Aneuploidy Screening","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2010.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}